EGFR and non-small cell lung carcinoma: In this work, we report a fluorogenic probe (HX103) and establish a proof-of-concept multicolor fluorescence-activated cell sorting (FACS) assay with HX103 to fully quantify active-EGFR in tumors from NSCLC patients.